TuisRHHBY • OTCMKTS
add
Roche Holdings AG Basel ADR Common Stock
Vorige sluiting
$35,29
Dagwisseling
$35,39 - $35,64
Jaarwisseling
$29,20 - $42,43
Markkapitalisasie
233,72 mjd USD
Gemiddelde volume
1,15 m
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(CHF) | Jun. 2024info | J/J-verandering |
---|---|---|
Inkomste | 15,38 mjd | 0,46% |
Bedryfskoste | 6,22 mjd | 0,75% |
Netto inkomste | 3,13 mjd | -12,32% |
Netto winsgrens | 20,35 | -12,70% |
Wins per aandeel | — | — |
EBITDA | 6,17 mjd | 1,01% |
Effektiewe belastingkoers | 18,56% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(CHF) | Jun. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 8,81 mjd | 17,38% |
Totale bates | 95,79 mjd | 13,53% |
Totale aanspreeklikheid | 62,91 mjd | 16,44% |
Totale ekwiteit | 32,88 mjd | — |
Uitstaande aandele | 796,79 m | — |
Prys om te bespreek | 0,97 | — |
Opbrengs op bates | 14,16% | — |
Opbrengs op kapitaal | 19,64% | — |
Kontantvloei
Netto kontantverandering
(CHF) | Jun. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 3,13 mjd | -12,32% |
Kontant van bedrywe | 3,96 mjd | 0,20% |
Kontant van beleggings | -1,43 mjd | -494,40% |
Kontant van finansiering | -2,72 mjd | 34,29% |
Netto kontantverandering | -276,00 m | 56,57% |
Beskikbare kontantvloei | 3,19 mjd | -2,82% |
Meer oor
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. Roche is one of the few companies increasing their dividend every year, for 2020 as the 34th consecutive year.
F. Wikipedia
Gestig
01 Okt. 1896
Hoofkwartier
Webwerf
Werknemers
103 605